Biotech sues to prevent competitors from bringing out generic versions of its drug Amrix.

Drug firms take Mylan and Barr to court for infringement of muscle-relaxant patent.

Big pharma company agrees to acquire maker of biosurgical products for $438 million in cash.

The biotech reports positive data for Avastin breast cancer study.

The big pharma jumps into the acquisition game to pad its pipeline.